The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Hepatitis A Virus: From Discovery to Vaccines
Abstract
Hepatitis A virus (HAV), the causative agent of type A viral hepatitis, is an ancient human virus that was first identified almost 35 years ago. It has several characteristics that make it unique among the Picornaviridae , particularly in terms of its mechanisms of polyprotein processing and virion morphogenesis, and which likely contribute to its pathobiology. Although efficacious vaccines containing formalin-inactivated virus produced in cell culture have been licensed in multiple countries, their use has been limited by cost considerations. Changes in public health sanitation and generally increasing standards of living are leading to a decreasing incidence of acute hepatitis A worldwide, with the result that the prevalence of preexisting immunity among adults is declining in many regions. These changes in the epidemiology of HAV may paradoxically enhance the disease burden, as greater numbers of individuals become infected at older ages when disease is more likely to be clinically evident, thus providing greater incentives for vaccine utilization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412
(1999) · PsycEXTRA Dataset · doi:10.1037/e547812006-001 · Cited by 1,131
Feinstone, S. M., Kapikian, A. Z., & Purcell, R. H. (1973) · Science · doi:10.1126/science.182.4116.1026 · Cited by 865
Evasion of intracellular host defence by hepatitis C virus
Gale, M., & Foy, E. M. (2005) · Nature · doi:10.1038/nature04078 · Cited by 633
A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children
Werzberger, A., Mensch, B., Kuter, B., Brown, L., Lewis, J., Sitrin, R., Miller, W., Shouval, D., Wiens, B., Calandra, G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208133270702 · Cited by 540
Protection Against Hepatitis A by an Inactivated Vaccine
Innis, B. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510410040030 · Cited by 417
Li, K., Chen, Z., Kato, N., Gale, M., & Lemon, S. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414139200 · Cited by 367
Self-citationIncidence of Hepatitis A in the United States in the Era of Vaccination
Wasley, A. (2005) · JAMA · doi:10.1001/jama.294.2.194 · Cited by 273
Incidence of Hepatitis A in Israel Following Universal Immunization of Toddlers
Dagan, R. (2005) · JAMA · doi:10.1001/jama.294.2.202 · Cited by 261
The Human Homolog of HAVcr-1 Codes for a Hepatitis A Virus Cellular Receptor
Feigelstock, D., Thompson, P., Mattoo, P., Zhang, Y., & Kaplan, G. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6621-6628.1998 · Cited by 247
Cited by
Picornavirus and enterovirus diversity with associated human diseases
Tapparel, C., Siegrist, F., Petty, T. J., & Kaiser, L. (2013) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2012.10.016 · Cited by 444
Cytoplasmic vacuolization in cell death and survival
Shubin, A. V., Demidyuk, I. V., Komissarov, A. A., Rafieva, L. M., & Kostrov, S. V. (2016) · Oncotarget · doi:10.18632/oncotarget.10150 · Cited by 372
Immune responses and immunopathology in acute and chronic viral hepatitis
Shin, E.-C., Sung, P. S., & Park, S.-H. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.69 · Cited by 365
Nelson, N. P., Weng, M. K., Hofmeister, M. G., Moore, K. L., Doshani, M., Kamili, S., Koneru, A., Haber, P., Hagan, L., Romero, J. R., et al. (2020) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6905a1 · Cited by 264
Natural history, clinical manifestations, and pathogenesis of hepatitis A.
Shin, E.-C., & Jeong, S.-H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031708 · Cited by 170
Metadata
- Authors
- Martin, A., & Lemon, S. M.
- Venue
- Hepatology
- Published
- 2006-02
- Volume
- 43
- Issue
- Supplement 1
- Pages
- S164-S172
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2074261782
- Cited by
- 299
- References
- 33
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatitis A Virus: From Discovery to Vaccines. https://app.cochat.ai/papers/10.1002/hep.21052
- The paper
- Martin, A., & Lemon, S. M. (2006). Hepatitis A Virus: From Discovery to Vaccines. Hepatology. https://doi.org/10.1002/hep.21052
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.